Literature DB >> 18648746

Primary CD56+ NK/T-cell lymphoma of the rectum accompanied with refractory ulcerative colitis.

Kazuki Kakimoto1, Takuya Inoue, Takashi Nishikawa, Kumi Ishida, Ken Kawakami, Takanori Kuramoto, Yosuke Abe, Eijiro Morita, Naoko Murano, Ken Toshina, Mitsuyuki Murano, Eiji Umegaki, Yutaro Egashira, Junji Okuda, Nobuhiko Tanigawa, Ichiro Hirata, Ken-Ichi Katsu, Kazuhide Higuchi.   

Abstract

A case of primary NK/T-cell lymphoma of the rectum accompanied with ulcerative colitis (UC) in a 73-year-old man is reported. He had a 6-year history of repeated admission to our hospital for UC. Total colonoscopy performed 4 months after resolution of refractory UC complicated by cytomegalovirus colitis showed a markedly submucosal tumor in the rectum, which was histologically diagnosed as malignant lymphoma. The findings of computed tomography of the chest and abdomen, gallium scintigraphy, abdominal ultrasonography, and upper gastrointestinal endoscopy showed no abnormal lesions. Therefore, based on a diagnosis of localized rectal lymphoma with UC, proctocolectomy was performed. The resected specimen showed three submucosal tumors in the rectum with local nodal involvement. Histologically, the tumors were characterized by diffusely infiltrating sheets of large atypical lymphoid cells, which were negative for CD4, CD8, and CD20 but were positive for CD56, CD3, and granzyme B. The presence of Epstein-Barr virus (EBV) infection in neoplastic cells was shown by in situ hybridization for EBV-encoded early small RNA1 (EBER-1). Based on these findings, the patient was diagnosed with primary CD56+ NK/T-cell lymphoma of the rectum (stage IIE). This is the first case report of primary rectal NK/T-cell lymphoma accompanied with UC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18648746     DOI: 10.1007/s00535-008-2192-7

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  41 in total

Review 1.  The role of EBV in post-transplant malignancies: a review.

Authors:  P Hopwood; D H Crawford
Journal:  J Clin Pathol       Date:  2000-04       Impact factor: 3.411

2.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

3.  Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine.

Authors:  Gerald A Dayharsh; Edward V Loftus; William J Sandborn; William J Tremaine; Alan R Zinsmeister; Thomas E Witzig; William R Macon; Lawrence J Burgart
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

4.  Refractory ulcerative colitis accompanied with cytomegalovirus colitis and multiple liver abscesses: a case report.

Authors:  Takuya Inoue; Ichiro Hirata; Yutaro Egashira; Kumi Ishida; Ken Kawakami; Eijiro Morita; Naoko Murano; Shingo Yasumoto; Mitsuyuki Murano; Ken Toshina; Takashi Nishikawa; Norihiro Hamamoto; Ken Nakagawa; Ken-Ichi Katsu
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

5.  Inflammatory bowel disease is not associated with an increased risk of lymphoma.

Authors:  J D Lewis; W B Bilker; C Brensinger; J J Deren; D J Vaughn; B L Strom
Journal:  Gastroenterology       Date:  2001-11       Impact factor: 22.682

6.  Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis.

Authors:  M Cottone; G Pietrosi; G Martorana; A Casà; G Pecoraro; L Oliva; A Orlando; M Rosselli; A Rizzo; L Pagliaro
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

7.  Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study.

Authors:  Neeraja Kambham; Rohini Vij; Christine A Cartwright; Teri Longacre
Journal:  Am J Surg Pathol       Date:  2004-03       Impact factor: 6.394

8.  Expression of cytoplasmic CD3 epsilon proteins in activated human adult natural killer (NK) cells and CD3 gamma, delta, epsilon complexes in fetal NK cells. Implications for the relationship of NK and T lymphocytes.

Authors:  L L Lanier; C Chang; H Spits; J H Phillips
Journal:  J Immunol       Date:  1992-09-15       Impact factor: 5.422

9.  Lymphoma in inflammatory bowel disease.

Authors:  A J Greenstein; G E Mullin; J A Strauchen; T Heimann; H D Janowitz; A H Aufses; D B Sachar
Journal:  Cancer       Date:  1992-03-01       Impact factor: 6.860

10.  Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease.

Authors:  W R Connell; M A Kamm; M Dickson; A M Balkwill; J K Ritchie; J E Lennard-Jones
Journal:  Lancet       Date:  1994-05-21       Impact factor: 79.321

View more
  3 in total

1.  Primary duodenal NK/T-cell lymphoma with massive bleeding: A case report.

Authors:  Jian-Zhong Li; Jin Tao; Dan-Yun Ruan; Yi-Dong Yang; Ya-Shi Zhan; Xing Wang; Yu Chen; Si-Chi Kuang; Chun-Kui Shao; Bin Wu
Journal:  World J Clin Oncol       Date:  2012-06-10

Review 2.  Follicular dendritic cell sarcoma presenting as a thyroid mass: an unusual case report and literature review.

Authors:  Ting Zhang; Liang He; Zhihong Wang; Wenwu Dong; Wei Sun; Ping Zhang; Hao Zhang
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

3.  Case Report: Primary NK/T Cell Lymphoma Nasal Type of the Colon With Multiple Intestinal Perforations.

Authors:  Yan Zhang; Weiping Liu; Xinyue Zhang; Bing Wu
Journal:  Front Oncol       Date:  2021-03-17       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.